17 results
S-3
EX-4.5
OMIC
Singular Genomics Systems Inc
19 Jul 22
Shelf registration
4:16pm
relating thereto;
(2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions … or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and
(4
S-3
EX-1.2
OMIC
Singular Genomics Systems Inc
19 Jul 22
Shelf registration
4:16pm
of, or accesses to Confidential Data, nor any such actual or reasonably suspected incidents under internal review or investigation. The Company and its … Adverse Effect, there has been no complaint or audit, proceeding, investigation (formal or informal) or claim made against the Company in the past five (5
424B4
nrvm9 au6
28 May 21
Prospectus supplement with pricing info
12:00am
S-1/A
eaqb2mlbbxing
12 May 21
IPO registration (amended)
5:12pm
S-1
3p4ydm9dr b0cujta3d
7 May 21
IPO registration
4:18pm
S-1
EX-10.6
ol8dqzswa
7 May 21
IPO registration
4:18pm
S-1
EX-10.11
3h44 at8eg02036
7 May 21
IPO registration
4:18pm
S-1
EX-10.5
7yvn7v6 sasm52pm6
7 May 21
IPO registration
4:18pm
DRS/A
EX-10.11
q24kdf78mb
26 Apr 21
Draft registration statement (amended)
12:00am
DRS/A
mau11g
26 Apr 21
Draft registration statement (amended)
12:00am
DRS
7qw3i5t un
22 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next